Reducing breast cancer recurrence with                      weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery                      and Good Health for You (ENERGY) Trial

Cheryl L. Rock; Tim E. Byers; Graham A. Colditz; Wendy Demark-Wahnefried; Patricia A. Ganz; Kathleen Y. Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A. Parker; Rebecca L. Sedjo; Holly Wyatt; Cheryl Rock; Bilge Pakiz; Barbara Parker; Chis Zoumas; Shirley Flatt; Hava Shoshana Barkai; Dennis Heath; Lea Jacinto; Mila Pruitt; Patricia Ganz; Tim Byers; Rebecca Sedjo; James Hill; Jhenny Hernandez; Kim Gorman; Carmen Faust; Anna Van Pelt; Kathleen Wolin; Casey Fagin; Jennifer Tappenden; Sonya Izadi; Helen Krontiras; Maria Azrad; Cindy Blair; Lahnor Powell; Laura Lee Goree; Karen Kubas

doi:10.1016/j.cct.2012.12.003

Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial

Cheryl L. Rock^*, Tim E. Byers, Graham A. Colditz, Wendy Demark-Wahnefried, Patricia A. Ganz, Kathleen Y. Wolin, Anthony Elias, Helen Krontiras, Jingxia Liu, Michael Naughton, Bilgé Pakiz, Barbara A. Parker, Rebecca L. Sedjo, Holly Wyatt, Cheryl Rock, Bilge Pakiz, Barbara Parker, Chis Zoumas, Shirley Flatt, Hava Shoshana BarkaiDennis Heath, Lea Jacinto, Mila Pruitt, Patricia Ganz, Tim Byers, Rebecca Sedjo, James Hill, Jhenny Hernandez, Kim Gorman, Carmen Faust, Anna Van Pelt, Kathleen Wolin, Casey Fagin, Jennifer Tappenden, Sonya Izadi, Helen Krontiras, Maria Azrad, Cindy Blair, Lahnor Powell, Laura Lee Goree, Karen Kubas

^*Corresponding author for this work

Entrepreneurship (ENTR)

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Abstract

Breast cancer is the most common invasive cancer among women in developed countries. Obesity is a major risk factor for breast cancer recurrence and mortality in both pre- and postmenopausal women. Co-morbid medical conditions are common among breast cancer survivors. The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study is a 4-year randomized clinical trial of 693 overweight/obese women aged ≥21years diagnosed with any early stage breast cancer (stages I[≥1cm]-III) within the previous five years, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities, and to enable future exploration of biochemical mechanisms linking obesity to lower likelihood of disease-free survival. This trial is strategically designed as a vanguard for a fully-powered trial of women who will be evaluated for breast cancer recurrence and disease-free survival. Participants were recruited between 2010 and 2012 at four sites, had completed initial therapies, and had a body mass index between 25 and 45kg/m². The intervention featured a group-based cognitive-behavioral weight loss program with telephone counseling and tailored newsletters to support initial weight loss and subsequent maintenance, with the goal of 7% weight loss at two years. This study has high potential to have a major impact on clinical management and outcomes after a breast cancer diagnosis. This trial initiates the effort to establish weight loss support for overweight or obese breast cancer survivors as a new standard of clinical care.

Original language	English (US)
Pages (from-to)	282-295
Number of pages	14
Journal	Contemporary Clinical Trials
Volume	34
Issue number	2
DOIs	https://doi.org/10.1016/j.cct.2012.12.003
State	Published - Mar 1 2013

Funding

This publication also was made possible by grant number UL1 RR024992 from the National Center for Research Resources (NCRR) , a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research . Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or NIH. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, for the use of the Tissue Procurement Core, which provided sample storage and processing (supported in part by an NCI Cancer Center Support Grant CA91842). This study was supported by NCI grant CA148791 . Preliminary studies to develop the intervention components were supported by NCI grants CA90413 , CA101489 , CA81191 , and CA106919 . Management of stored biological samples at the UCSD Coordinating Center was facilitated by the Nutrition Shared Resource of the Moores UCSD Cancer Center (NCI Cancer Center Support Grant CA23100).

Keywords

Breast cancer
Co-morbidities
Obesity
Quality of life
Weight reduction

ASJC Scopus subject areas

Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cct.2012.12.003

Cite this

Rock, C. L., Byers, T. E., Colditz, G. A., Demark-Wahnefried, W., Ganz, P. A., Wolin, K. Y., Elias, A., Krontiras, H., Liu, J., Naughton, M., Pakiz, B., Parker, B. A., Sedjo, R. L., Wyatt, H., Rock, C., Pakiz, B., Parker, B., Zoumas, C., Flatt, S., ... Kubas, K. (2013). Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemporary Clinical Trials, 34(2), 282-295. https://doi.org/10.1016/j.cct.2012.12.003

@article{a2145568d3a44320a9096fb4520a6a92,

title = "Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial",

abstract = "Breast cancer is the most common invasive cancer among women in developed countries. Obesity is a major risk factor for breast cancer recurrence and mortality in both pre- and postmenopausal women. Co-morbid medical conditions are common among breast cancer survivors. The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study is a 4-year randomized clinical trial of 693 overweight/obese women aged ≥21years diagnosed with any early stage breast cancer (stages I[≥1cm]-III) within the previous five years, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities, and to enable future exploration of biochemical mechanisms linking obesity to lower likelihood of disease-free survival. This trial is strategically designed as a vanguard for a fully-powered trial of women who will be evaluated for breast cancer recurrence and disease-free survival. Participants were recruited between 2010 and 2012 at four sites, had completed initial therapies, and had a body mass index between 25 and 45kg/m2. The intervention featured a group-based cognitive-behavioral weight loss program with telephone counseling and tailored newsletters to support initial weight loss and subsequent maintenance, with the goal of 7% weight loss at two years. This study has high potential to have a major impact on clinical management and outcomes after a breast cancer diagnosis. This trial initiates the effort to establish weight loss support for overweight or obese breast cancer survivors as a new standard of clinical care.",

keywords = "Breast cancer, Co-morbidities, Obesity, Quality of life, Weight reduction",

author = "Rock, {Cheryl L.} and Byers, {Tim E.} and Colditz, {Graham A.} and Wendy Demark-Wahnefried and Ganz, {Patricia A.} and Wolin, {Kathleen Y.} and Anthony Elias and Helen Krontiras and Jingxia Liu and Michael Naughton and Bilg{\'e} Pakiz and Parker, {Barbara A.} and Sedjo, {Rebecca L.} and Holly Wyatt and Cheryl Rock and Bilge Pakiz and Barbara Parker and Chis Zoumas and Shirley Flatt and Barkai, {Hava Shoshana} and Dennis Heath and Lea Jacinto and Mila Pruitt and Patricia Ganz and Tim Byers and Rebecca Sedjo and James Hill and Jhenny Hernandez and Kim Gorman and Carmen Faust and {Van Pelt}, Anna and Kathleen Wolin and Casey Fagin and Jennifer Tappenden and Sonya Izadi and Helen Krontiras and Maria Azrad and Cindy Blair and Lahnor Powell and {Lee Goree}, Laura and Karen Kubas",

year = "2013",

month = mar,

day = "1",

doi = "10.1016/j.cct.2012.12.003",

language = "English (US)",

volume = "34",

pages = "282--295",

journal = "Contemporary Clinical Trials",

issn = "1551-7144",

publisher = "Elsevier Inc.",

number = "2",

}

Rock, CL, Byers, TE, Colditz, GA, Demark-Wahnefried, W, Ganz, PA, Wolin, KY, Elias, A, Krontiras, H, Liu, J, Naughton, M, Pakiz, B, Parker, BA, Sedjo, RL, Wyatt, H, Rock, C, Pakiz, B, Parker, B, Zoumas, C, Flatt, S, Barkai, HS, Heath, D, Jacinto, L, Pruitt, M, Ganz, P, Byers, T, Sedjo, R, Hill, J, Hernandez, J, Gorman, K, Faust, C, Van Pelt, A, Wolin, K, Fagin, C, Tappenden, J, Izadi, S, Krontiras, H, Azrad, M, Blair, C, Powell, L, Lee Goree, L & Kubas, K 2013, 'Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial', Contemporary Clinical Trials, vol. 34, no. 2, pp. 282-295. https://doi.org/10.1016/j.cct.2012.12.003

Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. / Rock, Cheryl L.; Byers, Tim E.; Colditz, Graham A. et al.
In: Contemporary Clinical Trials, Vol. 34, No. 2, 01.03.2013, p. 282-295.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Reducing breast cancer recurrence with weight loss, a vanguard trial

T2 - The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial

AU - Rock, Cheryl L.

AU - Byers, Tim E.

AU - Colditz, Graham A.

AU - Demark-Wahnefried, Wendy

AU - Ganz, Patricia A.

AU - Wolin, Kathleen Y.

AU - Elias, Anthony

AU - Krontiras, Helen

AU - Liu, Jingxia

AU - Naughton, Michael

AU - Pakiz, Bilgé

AU - Parker, Barbara A.

AU - Sedjo, Rebecca L.

AU - Wyatt, Holly

AU - Rock, Cheryl

AU - Pakiz, Bilge

AU - Parker, Barbara

AU - Zoumas, Chis

AU - Flatt, Shirley

AU - Barkai, Hava Shoshana

AU - Heath, Dennis

AU - Jacinto, Lea

AU - Pruitt, Mila

AU - Ganz, Patricia

AU - Byers, Tim

AU - Sedjo, Rebecca

AU - Hill, James

AU - Hernandez, Jhenny

AU - Gorman, Kim

AU - Faust, Carmen

AU - Van Pelt, Anna

AU - Wolin, Kathleen

AU - Fagin, Casey

AU - Tappenden, Jennifer

AU - Izadi, Sonya

AU - Krontiras, Helen

AU - Azrad, Maria

AU - Blair, Cindy

AU - Powell, Lahnor

AU - Lee Goree, Laura

AU - Kubas, Karen

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Breast cancer is the most common invasive cancer among women in developed countries. Obesity is a major risk factor for breast cancer recurrence and mortality in both pre- and postmenopausal women. Co-morbid medical conditions are common among breast cancer survivors. The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study is a 4-year randomized clinical trial of 693 overweight/obese women aged ≥21years diagnosed with any early stage breast cancer (stages I[≥1cm]-III) within the previous five years, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities, and to enable future exploration of biochemical mechanisms linking obesity to lower likelihood of disease-free survival. This trial is strategically designed as a vanguard for a fully-powered trial of women who will be evaluated for breast cancer recurrence and disease-free survival. Participants were recruited between 2010 and 2012 at four sites, had completed initial therapies, and had a body mass index between 25 and 45kg/m2. The intervention featured a group-based cognitive-behavioral weight loss program with telephone counseling and tailored newsletters to support initial weight loss and subsequent maintenance, with the goal of 7% weight loss at two years. This study has high potential to have a major impact on clinical management and outcomes after a breast cancer diagnosis. This trial initiates the effort to establish weight loss support for overweight or obese breast cancer survivors as a new standard of clinical care.

AB - Breast cancer is the most common invasive cancer among women in developed countries. Obesity is a major risk factor for breast cancer recurrence and mortality in both pre- and postmenopausal women. Co-morbid medical conditions are common among breast cancer survivors. The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study is a 4-year randomized clinical trial of 693 overweight/obese women aged ≥21years diagnosed with any early stage breast cancer (stages I[≥1cm]-III) within the previous five years, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities, and to enable future exploration of biochemical mechanisms linking obesity to lower likelihood of disease-free survival. This trial is strategically designed as a vanguard for a fully-powered trial of women who will be evaluated for breast cancer recurrence and disease-free survival. Participants were recruited between 2010 and 2012 at four sites, had completed initial therapies, and had a body mass index between 25 and 45kg/m2. The intervention featured a group-based cognitive-behavioral weight loss program with telephone counseling and tailored newsletters to support initial weight loss and subsequent maintenance, with the goal of 7% weight loss at two years. This study has high potential to have a major impact on clinical management and outcomes after a breast cancer diagnosis. This trial initiates the effort to establish weight loss support for overweight or obese breast cancer survivors as a new standard of clinical care.

KW - Breast cancer

KW - Co-morbidities

KW - Obesity

KW - Quality of life

KW - Weight reduction

UR - http://www.scopus.com/inward/record.url?scp=84872526639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872526639&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2012.12.003

DO - 10.1016/j.cct.2012.12.003

M3 - Article

C2 - 23266440

AN - SCOPUS:84872526639

SN - 1551-7144

VL - 34

SP - 282

EP - 295

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

IS - 2

ER -